Skip to content
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
February 2019

3rd EURORDIS Multi-Stakeholder Symposium on Improving Patients’ Access to Rare Disease Therapies


Let’s make a pact to ensure patients’ sustainable access to rare disease therapies

13-14 February 2019 
Crowne Plaza Brussels – Le Palace, Rue Gineste 3, 1210 Brussels, Belgium
Metro Station: Rogier

Over 250 people gathered at this event, including rare disease patients, patient advocates, healthcare industry, consultants, investors, ERN clinical representatives, academia, healthcare professionals, researchers, payer bodies, HTA agencies, National Competent Authorities, regulators, policy makers, and government workers.

Some of the important take-home messages include the recognition that multi-stakeholder collaboration is a fundamental condition to achieving patient access to rare disease medicines; that there is a need for a more trusted and transparent cooperation between payers and companies; and that the expectations for the European Reference Networks (ERNs) to be an important facilitator in evidence generation building is also an area of high interest that will be monitored closely over the coming years.

EURORDIS-Rare Diseases Europe is now gathering the input developed in the plenary and breakout sessions and will include them in the outcomes document as a roadmap for all parties to collaborate in a process to improve patients’ access to rare disease medicines. The final version of the roadmap document will be shared in April 2019.

Recording of the Symposium Plenary Session

Pre-Symposium Webinars

Two webinars have taken place ahead of this Symposium to provide the knowledge needed to effectively participate in discussions at the event.

First pre-symposium webinar

Covering topics in breakout sessions 2 and 3. Webinar speakers:

  • Anna Bucsics, University of Vienna; Project Advisor, Mechanism of Coordinated Access to orphan medicinal products (MoCA)
  • Simone Boselli, Public Affairs Director, EURORDIS-Rare Diseases Europe

Second pre-symposium webinar

Covering topics in breakout sessions 1 and 4. Webinar speakers:

  • Victoria Hedley, Newcastle University, Rare Disease Policy Manager, Newcastle University John Walton Muscular Dystrophy Research Centre, MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine
  • Simone Boselli, Public Affairs Director, EURORDIS-Rare Diseases Europe

Documents

Official partners

EPF.jpg                       efpia_2.jpg                         eurocope.jpg

europabio_0.jpg                                HOPE_0.jpg                                  PGEU.jpg

eahp_logo_0.jpg                           htai_logo.png         ispor_logo

Contact

Questions regarding this event? Please contact Martina Bergna, Events Junior Manager: martina.bergna@eurordis.org

Downloads

This site is registered on wpml.org as a development site.